IGFBP3 and chronic obstructive pulmonary disease: The UPR has previously been investigated in the context of chronic obstructive pulmonary disease and cystic fibrosis13, and a recent study showed that XBP1s-mediated upregulation of insulin-like growth factor binding protein-3 (IGFBP3) promotes NSCLC invasion and metastasis14.